United Kingdom
# |
Name |
Free Cash Flow Yield |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
12.65% |
Feb. 3, 2025 | USD 2.89 | -0.48% |
|
United Kingdom |
|
2 |
11.47% |
Feb. 3, 2025 | USD 0.80 | 0.38% |
|
United Kingdom |
|
3 |
9.50% |
Feb. 3, 2025 | USD 0.76 | 0.22% |
|
United Kingdom |
|
4 |
9.50% |
Feb. 3, 2025 | USD 0.24 | -0.40% |
|
United Kingdom |
|
5 |
7.93% |
Feb. 3, 2025 | USD 17.39 | -0.08% |
|
United Kingdom |
|
6 |
7.41% |
Feb. 3, 2025 | USD 0.65 | -1.49% |
|
United Kingdom |
|
7 |
6.97% |
Feb. 3, 2025 | USD 28.38 | -0.06% |
|
United Kingdom |
|
8 |
6.78% |
Feb. 3, 2025 | USD 1.42 | -3.02% |
|
United Kingdom |
|
9 |
5.37% |
Feb. 3, 2025 | USD 38.56 | 0.38% |
|
United Kingdom |
|
10 |
5.31% |
Feb. 3, 2025 | USD 4.67 | 0.65% |
|
United Kingdom |
|
11 |
4.95% |
Feb. 3, 2025 | USD 25.30 | -1.17% |
|
United Kingdom |
|
12 |
3.86% |
Feb. 3, 2025 | USD 3.02 | -1.33% |
|
United Kingdom |
|
13 |
3.17% |
Feb. 3, 2025 | USD 56.22 | -0.33% |
|
United Kingdom |
|
14 |
3.02% |
Feb. 3, 2025 | USD 140.24 | -0.22% |
|
United Kingdom |
|
15 |
2.97% |
Feb. 3, 2025 | USD 37.51 | -0.51% |
|
United Kingdom |
|
16 |
1.62% |
Feb. 3, 2025 | USD 12.79 | 0.04% |
|
United Kingdom |
|
17 |
-0.58% |
Feb. 3, 2025 | USD 0.32 | 2.99% |
|
United Kingdom |
|
18 |
-1.91% |
Feb. 3, 2025 | USD 0.20 | -2.58% |
|
United Kingdom |
|
19 |
-4.31% |
Feb. 3, 2025 | USD 14.61 | -1.71% |
|
United Kingdom |
|
20 |
-7.39% |
Feb. 3, 2025 | USD 0.22 | 1.80% |
|
United Kingdom |
|
21 |
-9.14% |
Feb. 3, 2025 | USD 5.04 | -2.51% |
|
United Kingdom |
|
22 |
-9.26% |
Feb. 3, 2025 | USD 0.16 | 0.38% |
|
United Kingdom |
|
23 |
-9.30% |
Feb. 3, 2025 | USD 0.59 | 0.38% |
|
United Kingdom |
|
24 |
-12.14% |
Feb. 3, 2025 | USD 1.98 | 0.38% |
|
United Kingdom |
|
25 |
-13.08% |
Feb. 3, 2025 | USD 0.07 | -16.83% |
|
United Kingdom |
|
26 |
-15.57% |
Feb. 3, 2025 | USD 0.25 | 0.38% |
|
United Kingdom |
|
27 |
-16.50% |
Feb. 3, 2025 | USD 0.12 | -0.69% |
|
United Kingdom |
|
28 |
-16.58% |
Feb. 3, 2025 | USD 0.09 | -6.74% |
|
United Kingdom |
|
29 |
-20.45% |
Feb. 3, 2025 | USD 0.16 | 4.56% |
|
United Kingdom |
|
30 |
-23.37% |
Feb. 3, 2025 | USD 0.03 | 4.40% |
|
United Kingdom |
|
31 |
-24.64% |
Feb. 3, 2025 | USD 0.09 | -2.82% |
|
United Kingdom |
|
32 |
-25.65% |
Feb. 3, 2025 | USD 0.24 | 1.95% |
|
United Kingdom |
|
33 |
-26.85% |
Feb. 3, 2025 | USD 0.57 | 0.38% |
|
United Kingdom |
|
34 |
-26.97% |
Feb. 3, 2025 | USD 0.01 | -9.39% |
|
United Kingdom |
|
35 |
-28.73% |
Feb. 3, 2025 | USD 0.70 | -3.05% |
|
United Kingdom |
|
36 |
-29.97% |
Feb. 3, 2025 | USD 0.20 | -0.86% |
|
United Kingdom |
|
37 |
-31.53% |
Feb. 3, 2025 | USD 0.23 | 1.77% |
|
United Kingdom |
|
38 |
-32.34% |
Feb. 3, 2025 | USD 0.03 | 1.77% |
|
United Kingdom |
|
39 |
-37.48% |
Feb. 3, 2025 | USD 0.03 | -12.38% |
|
United Kingdom |
|
40 |
-40.22% |
Feb. 3, 2025 | USD 0.04 | -11.51% |
|
United Kingdom |
|
41 |
-52.25% |
Feb. 3, 2025 | USD 4.20 | -6.92% |
|
United Kingdom |
|
42 |
-56.85% |
Feb. 3, 2025 | USD 0.21 | 3.52% |
|
United Kingdom |
|
43 |
-59.23% |
Feb. 3, 2025 | USD 0.13 | 4.36% |
|
United Kingdom |
|
44 |
-65.34% |
Feb. 3, 2025 | USD 0.05 | 0.38% |
|
United Kingdom |
|
45 |
-105.09% |
Feb. 3, 2025 | USD 0.05 | 1.59% |
|
United Kingdom |
|
46 |
-145.76% |
Feb. 3, 2025 | USD 0.03 | -3.20% |
|
United Kingdom |
The Healthcare company in United Kingdom with the highest Free Cash Flow Yield is Spire Healthcare Group plc (LSE: SPI.L) at 12.65%.
The Healthcare company in United Kingdom with the lowest Free Cash Flow Yield is Shield Therapeutics plc (LSE: STX.L) at -145.76%.
The top 10 Healthcare companies in United Kingdom by Free Cash Flow Yield are Spire Healthcare Group plc, ECO Animal Health Group plc, Alliance Pharma plc, hVIVO plc, GSK plc, SDI Group plc, Hikma Pharmaceuticals PLC, Big Technologies plc, Bioventix PLC and Haleon plc.
The bottom 10 Healthcare companies in United Kingdom by Free Cash Flow Yield are Shield Therapeutics plc, GENinCode plc, Verici Dx plc, Oncimmune Holdings plc, Celadon Pharmaceuticals Plc, Hemogenyx Pharmaceuticals Plc, Roquefort Therapeutics plc, Synairgen plc, genedrive plc and Creo Medical Limited.